Masthead
 

Custom Search
ADVERTISEMENT
Today's Health Photos
BANGKOK (Reuters) - An Omani man who became Thailand's first case of Middle East Respiratory Sydnrome (MERS) has made a full recovery and will be discharged from hospital on Friday, Thailand's health minister said.










LONDON (Reuters) - Scientists conducting a major trial of a therapy that replaces the faulty gene responsible for cystic fibrosis say the treatment has showed significant benefit for the first time in patients' lung function.

SEATTLE (Reuters) - A previously undetected measles infection was found by an autopsy to be the underlying cause of a Washington state woman's death this spring, marking the first known U.S. fatality from the disease in 12 years, public health officials said on Thursday.










(Reuters Health) - In a new position paper, the American College of Physicians (ACP) lays out six strategies for bringing mental health and substance abuse care into primary care to better treat each patient as “a whole person.”

MONROVIA (Reuters) - Liberia confirmed a third Ebola case on Thursday, nearly two months after it was declared Ebola free, and officials said they were investigating whether the disease had spread through animals before resurfacing.










(Reuters) - U.S. health insurer Centene Corp will buy smaller rival Health Net Inc for $6.3 billion, underscoring the healthcare industry's rush to bulk up to negotiate better prices with suppliers and hospitals, and attract new customers.

(Reuters) - Vertex Pharmaceuticals Inc's unique combination therapy for a rare lung disorder was given the green light by U.S. health regulators, extending the company's reach to the most common form of genetic mutation responsible for cystic fibrosis.










WASHINGTON (Reuters) - The U.S. Navy is tripling paid maternity leave for women who serve in the Navy and Marine Corps from six to 18 weeks in the first year after birth.

KINSHASA (Reuters) - Health officials in Democratic Republic of Congo are investigating a possible outbreak of Ebola in a village about 270 km (170 miles) northeast of the capital Kinshasa, the government and the World Health Organization (WHO) said on Thursday.










(Reuters Health) - Oral tablets for grass pollen allergies, which are available in Europe and the U.S., offer only a small benefit for people with seasonal allergies, and more than half will have side effects from the medication, according to a new review of existing research.

ADVERTISEMENT
Log into your Thames Valley Portal
Video
loading